CIK 0001420720
- Non-accelerated filer
- Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262797813
- Phone
- +1 302-355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-17 | Isett Thomas Francis 3rd CEO and Executive Co-Chairman | Option exercise · Series B Warrants (Right to Buy) | +78,024 | $1,000.00 | $78.0M | 1,275,000 |
| 2020-03-12 | Isett Thomas Francis 3rd CEO and Executive Chairman | Grant or award · Stock Option (right to buy) | +975,000 | $1.43 | $1.4M | 1,275,000 |
| 2020-02-20 | Isett Thomas Francis 3rd CEO and Executive Chairman | Other acquisition | +121,976 | 1,275,000 | ||
| 2020-02-20 | Isett Thomas Francis 3rd CEO and Executive Chairman | Other disposition · Series A Warrants (Right to Buy) | −100,000 | $1,000.00 | $100.0M | 1,275,000 |
| 2020-02-20 | Isett Thomas Francis 3rd CEO and Executive Chairman | Other disposition · Series B Warrants (Right to Buy) | −21,976 | $1,000.00 | $22.0M | 1,275,000 |
| 2019-03-14 | DART KENNETH BRYAN 10% owner | Other acquisition | +1 | 1 |
Page 7 of 7 · 126 trades